Back to Search
Start Over
NK-cell Editing Mediates Epithelial-to-Mesenchymal Transition via Phenotypic and Proteomic Changes in Melanoma Cell Lines.
- Source :
-
Cancer research [Cancer Res] 2018 Jul 15; Vol. 78 (14), pp. 3913-3925. Date of Electronic Publication: 2018 May 11. - Publication Year :
- 2018
-
Abstract
- Tumor cell plasticity is a major obstacle for the cure of malignancies as it makes tumor cells highly adaptable to microenvironmental changes, enables their phenotype switching among different forms, and favors the generation of prometastatic tumor cell subsets. Phenotype switching toward more aggressive forms involves different functional, phenotypic, and morphologic changes, which are often related to the process known as epithelial-mesenchymal transition (EMT). In this study, we report natural killer (NK) cells may increase the malignancy of melanoma cells by inducing changes relevant to EMT and, more broadly, to phenotype switching from proliferative to invasive forms. In coculture, NK cells induced effects on tumor cells similar to those induced by EMT-promoting cytokines, including upregulation of stemness and EMT markers, morphologic transition, inhibition of proliferation, and increased capacity for Matrigel invasion. Most changes were dependent on the engagement of NKp30 or NKG2D and the release of cytokines including IFNγ and TNFα. Moreover, EMT induction also favored escape from NK-cell attack. Melanoma cells undergoing EMT either increased NK-protective HLA-I expression on their surface or downregulated several tumor-recognizing activating receptors on NK cells. Mass spectrometry-based proteomic analysis revealed in two different melanoma cell lines a partial overlap between proteomic profiles induced by NK cells or by EMT cytokines, indicating that various processes or pathways related to tumor progression are induced by exposure to NK cells. Significance: NK cells can induce prometastatic properties on melanoma cells that escape from killing, providing important clues to improve the efficacy of NK cells in innovative antitumor therapies. Cancer Res; 78(14); 3913-25. ©2018 AACR .<br /> (©2018 American Association for Cancer Research.)
- Subjects :
- Cell Line, Tumor
Cell Proliferation physiology
Coculture Techniques methods
Cytokines immunology
Histocompatibility Antigens Class I immunology
Humans
Interferon-gamma immunology
NK Cell Lectin-Like Receptor Subfamily K immunology
Natural Cytotoxicity Triggering Receptor 3 immunology
Phenotype
Proteomics methods
Up-Regulation immunology
Epithelial-Mesenchymal Transition immunology
Killer Cells, Natural immunology
Melanoma immunology
Proteome immunology
Subjects
Details
- Language :
- English
- ISSN :
- 1538-7445
- Volume :
- 78
- Issue :
- 14
- Database :
- MEDLINE
- Journal :
- Cancer research
- Publication Type :
- Academic Journal
- Accession number :
- 29752261
- Full Text :
- https://doi.org/10.1158/0008-5472.CAN-17-1891